UK Guideline on Management of BK Polyomavirus (BKPyV) Infection and Disease Following Kidney Transplantation

BTS BK Guideline Working Group

Research output: Other contribution

Abstract

BKPyV is a leading cause of renal graft function loss and to date there has been no national guideline on the management of this common infection. The lack of guidelines with community engagement and support has led to disparate approaches to screening and management. This lack of unity in approach means care outcomes are variable across Britain and hampers our ability to execute multi-centre clinical trials or establish the standard of best care for this condition.

This first set of BTS Guidelines for the management of BKPyV in renal transplant recipients will not align with the practice in all centres but it is hoped that through engagement with the community they can evolve to define best practice. At this point in time there are no specific anti-BKPyV treatments that can be recommended and this is clearly an element we hope can be revised in future editions of the guidelines as evidence and our approach evolves.
Original languageEnglish
TypeUK Guideline on Management of Bk Polyomavirus Infection and Disease Following Kidney Transplantation
Media of outputClinical Guideline (Web-based)
PublisherBritish Transplantation Society
Number of pages67
Publication statusPublished - 4 Dec 2024

Cite this